Effects of Yakson Method and Swaddling on Pain and Physiological Parameters

August 26, 2022 updated by: Aslihan Hacisalihoglu, Istanbul University - Cerrahpasa (IUC)

Effects of Yakson Method Applied by Mother and Swaddling on Pain and Physiological Parameters During Heel Stick in Newborn

Type of Study: The study was planned to be conducted in a randomized controlled experimental design.

Place and Time of the Research: Institutional permission will be obtained from the Balcalı Training and Research Hospital in Adana for the collection of research data. Researchers commit to start data collection after obtaining institutional permission. The data collection process will take 1 year after obtaining the institutional permission.

48 newborns who are suited the inclusion criteria will be included in the study. Participants will be assigned to 3 groups according to randomization: Swaddling, Yakson Method, and Control.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Total processing time and baby's crying time are calculated by watching video recordings. In order to find the total procedure time, starting from the puncture of the baby's heel, the time until the dry cotton is placed on the baby's heel after the blood collection process is completed is calculated. The heart rate and SpO2 are noted by the investigator during the heel lancing procedure. Pain assessment of infants is done by two independent neonatal nurses, apart from the researcher, by watching video recordings. The scores given by the two observers will be evaluated by making inter-observer harmony. Before the evaluation, the nurses will be trained about the scale and its evaluation.

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 4 weeks (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Inclusion Criteria for Newborn:

  • Born at term (38-42 weeks)
  • Healthy newborn
  • Absence of congenital anomaly
  • No analgesic or sedative medication has been administered in the last 6 hours
  • Parent's consent for inclusion in the study in accordance with the consent form

Inclusion Criteria for Mother:

  • Mother's willingness to participate in the study
  • The mother can be mobilized and not have a physical disability (so that she can appyl Yakson therapy for her baby)
  • Being communicative

Exclusion Criteria:

  • Babies whose blood cannot be drawn on the first try

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Yakson Method Group
  • The mother is informed about the benefits of the Yakson method.
  • Yakson method is taught practically to the mother. Education continues until the researcher is sure that the mother has done the method correctly. The mother starts the application 10 minutes before the heel lancing is done and continues for another 5 minutes after the heel lancing is done. During the application, the baby is recorded with the camera. Just before starting the Yakson method (initial assessment), at 10 minutes of the Yakson method (just before the heel lancing), during the heel lancing while the Yakson method is in progress, and 5 minutes after the procedure (just before the end of the tender touch), the newborn's pain and physiological parameters are evaluated. Evaluation results are recorded in the application observation form.
Yakson Method and Swaddling
Experimental: Swaddling Group
  • Parents are informed about the research and verbal consent is obtained.
  • Written consent is obtained with an informed consent form.
  • The Mother-Baby Information Form is filled.
  • Babies are fed 1 hour before blood collection.
  • And researher swaddling the baby
Yakson Method and Swaddling
No Intervention: Control Group

Parents are informed about the research and verbal consent is obtained.

  • Written consent is obtained with an informed consent form.
  • The Mother-Baby Information Form is filled.
  • Babies are fed 1 hour before blood collection.
  • Before starting the heel lancing, a pulse oximeter probe will be attached to the baby's left big toe.
  • Blood is taken from the right heel of the foot.
  • During the application, the baby is recorded with the camera.
  • Evaluation results are recorded in the application observation form.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal Infant Pain Scale (NIPS):
Time Frame: 1 year
This scale was developed in 1993 by Lawrence et al. for premature and newborns. The scale measures the infant's response to pain behaviorally. The total score of the scale ranges from 0 to 7, and scores higher than 3 indicate the presence of pain.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2022

Primary Completion (Anticipated)

September 1, 2023

Study Completion (Anticipated)

September 1, 2023

Study Registration Dates

First Submitted

August 25, 2022

First Submitted That Met QC Criteria

August 26, 2022

First Posted (Actual)

August 29, 2022

Study Record Updates

Last Update Posted (Actual)

August 29, 2022

Last Update Submitted That Met QC Criteria

August 26, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • IstanbulUC-AHacisalihoglu

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain During Heal Lancing

Clinical Trials on Nonfarmacology method

3
Subscribe